Home

Insights

PE

Zenotech Laboratories Ltd P/E Ratio

Zenotech Laboratories Ltd P/E Ratio

download
stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

17.3 K

stocks traded

Last Updated time: 12 Jul 9.00 AM

Image

Zenotech Laboratories Ltd

NSE: ZENOTECHLAB

PE

46.4

Last updated : 12 Jul 9.00 AM

Key Highlights

    The P/E Ratio of Zenotech Laboratories Ltd is 46.4 as of 12 Jul 9.00 AM .a1#The P/E Ratio of Zenotech Laboratories Ltd changed from 8.3 on March 2019 to 24.8 on March 2023 . This represents a CAGR of 31.48% over 4 years. a1#The Latest Trading Price of Zenotech Laboratories Ltd is ₹ 63.12 as of 12 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Pharmaceuticals industry is 37.3. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Zenotech Laboratories Ltd changed from ₹ 129.69 crore on March 2019 to ₹ 287.21 crore on March 2023 . This represents a CAGR of 17.24% over 5 years. a1#The Revenue of Zenotech Laboratories Ltd changed from ₹ 12.41 crore to ₹ 9.43 crore over 8 quarters. This represents a CAGR of -12.83% a1#The EBITDA of Zenotech Laboratories Ltd changed from ₹ 7.14 crore to ₹ 3.11 crore over 8 quarters. This represents a CAGR of -34.00% a1#The Net Pr of Zenotech Laboratories Ltd changed from ₹ 3.77 crore to ₹ 0.66 crore over 8 quarters. This represents a CAGR of -58.16% a1#The Dividend Payout of Zenotech Laboratories Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Zenotech Laboratories Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Zenotech Laboratories Ltd

Period
Mar '190
Mar '208.3
Mar '210
Mar '2213.9
Mar '2324.8

Company Fundamentals for Zenotech Laboratories Ltd

Market Cap

385 Cr

EPS

1.4

P/E Ratio (TTM) *

46.4

P/B Ratio (TTM) *

4.3

Day’s High

64.65

Day’s Low

62.2

DTE *

0.0

ROE *

9.2

52 Week High

81.0

52 Week Low

52.0

ROCE *

12.2

* All values are consolidated

Last Updated time: 12 Jul 9.00 AM

* All values are consolidated

Last Updated time: 12 Jul 9.00 AM

Image

Zenotech Laboratories Ltd

NSE: ZENOTECHLAB

PRICE

63.12

-0.75 (-1.17%)

stock direction

Last updated : 12 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Zenotech Laboratories Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Zenotech Laboratories Ltd

Market Value

385

Asset Value

33

10.5 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Zenotech Laboratories Ltd46385
Sun Pharmaceuticals Industries Ltd37378,675
Cipla Ltd28122,093
Divis Laboratories Ltd75120,480
Zydus Lifesciences Ltd30118,217
Dr Reddys Laboratories Ltd20112,137

Key Valuation Metric of Zenotech Laboratories Ltd

Earnings

8 Cr

46.4 X

PE Ratio

Market Cap

₹385.22Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

8 Cr

46.4 X

PE Ratio

Market Cap

₹385.22Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Zenotech Laboratories Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Zenotech Laboratories Ltd

Period
Mar '19130
Mar '2090
Mar '21214
Mar '22307
Mar '23287

* All values are a in crore

×

Historical Revenue of Zenotech Laboratories Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Zenotech Laboratories Ltd

Period
Jun '2212
Sep '2211
Dec '229
Mar '2311
Jun '239
Sep '2312
Dec '2311
Mar '249

* All values are a in crore

×

Historical EBITDA of Zenotech Laboratories Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Zenotech Laboratories Ltd

Period
Jun '227
Sep '226
Dec '224
Mar '235
Jun '234
Sep '236
Dec '236
Mar '243

* All values are a in crore

×

Historical Net Profit of Zenotech Laboratories Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Zenotech Laboratories Ltd

Period
Jun '224
Sep '223
Dec '221
Mar '234
Jun '231
Sep '233
Dec '233
Mar '241

* All values are a in crore

×

Historical Dividend Payout of Zenotech Laboratories Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Zenotech Laboratories Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Zenotech Laboratories Ltd

About Zenotech Laboratories Ltd

    Zenotech Laboratories Limited (Formerly Sunline Technologies Limited) was established in June, 1989. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. During financial year 2004-05, the Hon'ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s. Zenotech Technologies Limited with effect from November 1st , 2003. The Company had issued 91,82,500 equity shares to erstwhile shareholders of M/s. Zenotech Laboratories Pvt. Ltd. and resultant, the name of Company was changed to 'Zenotech Laboratories Ltd.' with effect from August 10, 2004. M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited were merged with the Company, on May 2, 2006 through Scheme of Amalgamation, effective from October 1, 2005. 15 generic chemical oncology products were launched by the Company in India. Besides, the Company launched its anesthesia range of products during 2006. Consequent to the consummation of the merger of Ranbaxy Laboratories Limited into SPIL on March 24, 2015, SPIL indirectly acquired 46.84 percent of the voting rights held by Ranbaxy in, and control over the Company and became Promoter of the Company along with Daiichi Sankyo Company Limited and resultant, the Open Offer concluded in August 2015. The Company started production from its newly commissioned Depot Injectable facility in FY 2019-20. It renovated its Biotech API manufacturing facility and the same was leased to Sun Pharmaceutical Industries Limited, for their R&D activities effective from July, 2021.

Zenotech Laboratories Ltd News Hub

News

Zenotech Laboratories to discuss results

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 1 Ma...

Read more

25 Apr 202410:39

News

Zenotech Laboratories to conduct board meeting

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 29 J...

Read more

18 Jan 202411:26

News

Zenotech Laboratories to convene board meeting

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 30 O...

Read more

20 Oct 202314:15

News

Zenotech Laboratories to conduct AGM

Zenotech Laboratories announced that the 34th Annual General Meeting (AGM) of the company ...

Read more

05 Sep 202315:25

News

Zenotech Laboratories to declare Quarterly Result

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 1 Au...

Read more

26 Jul 202312:46

News

Zenotech Laboratories to hold board meeting

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 28 A...

Read more

21 Apr 202316:49

Product Composition by Percentage (Revenue)

FAQs for PE of Zenotech Laboratories Ltd

What is Zenotech Laboratories Ltd current share price?

The current market price of Zenotech Laboratories Ltd as of July 12, 2024 is ₹63.12.

What is Zenotech Laboratories Ltd's market cap?

Zenotech Laboratories Ltd's market capitalisation stood at ₹385 Cr as of July 12, 2024

What are Zenotech Laboratories Ltd's total net assets?

According to Zenotech Laboratories Ltd's most recent financial filings, the company's net assets total ₹33.4 Cr.

Is Zenotech Laboratories Ltd making a profit or loss?

Zenotech Laboratories Ltd's net Profit as of July 12, 2024 is close to ₹8 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199